Erasca (ERAS) Other Operating Expenses (2020 - 2026)
Erasca's (ERAS) quarterly Other Operating Expenses came in at $150.0 million in Q1 2026, up 7400.0% on a QoQ basis from $2.0 million in Q3 2025.
Analysis
Erasca (ERAS) Other Operating Expenses (2020 - 2026) Analysis & Trends
Erasca (ERAS) has 6 years of Other Operating Expenses data on file, last reported at $150.0 million in Q1 2026.
- Quarterly Other Operating Expenses changed N/A year-over-year to $150.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $159.5 million (up 608.89% YoY) and the FY2025 annual result came in at $9.5 million, down 57.78% from the prior year.
- Other Operating Expenses rose to $150.0 million in Q1 2026, from $2.0 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $150.0 million in Q1 2026 to a low of $2.0 million in Q1 2022.
- A 4-year average of $47.3 million and a median of $15.0 million in 2024 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses slumped 45.65% — and 2025, when it slumped 66.67%.
- Tracing ERAS's Other Operating Expenses over 4 years: stood at $100.0 million in 2022, then slumped by 77.5% to $22.5 million in 2024, then sank by 91.11% to $2.0 million in 2025, then soared by 7400.0% to $150.0 million in 2026.
- The last three Other Operating Expenses figures came in at $150.0 million (Q1 2026), $2.0 million (Q3 2025), and $7.5 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Erasca | 5.04 Bn | 5.04 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 150.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 7.50 Mn |
| Jun 30, 2024 | 22.50 Mn |
| Dec 31, 2022 | 100.00 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Sep 30, 2021 | 19.18 Mn |
| Jun 30, 2021 | 5.49 Mn |
| Mar 31, 2021 | 3.68 Mn |
| Dec 31, 2020 | 54.00 Mn |
| Sep 30, 2020 | 75,000.00 |